Newsletter | Yinfeng Low Temperature was invited to participate in the "International Conference on Health and Behavioral Science"
Release time:
2022-12-19
On December 19, 2022, the International Conference on Health and Behavioral Sciences, hosted by Shandong University of Finance and Economics, was successfully held. Yinfeng Cryogen, as a high-profile leader in the development of cryogenic medicine, was invited to attend the meeting.
The conference was launched online, aiming to introduce the cutting-edge theoretical progress and benchmarking industry practice of the international medical care and health industry into our province, and provide international experience and think tank suggestions for the implementation of the "top ten industries" in our province. The conference invited outstanding entrepreneurs in the industry to conduct online exchanges and share excellent papers, mainly focusing on the prevention of infectious diseases of the new crown epidemic, applied behavioral science to prevent and control epidemics, translational medicine and innovation, health quality and medical safety, the developing medical and health field, public health emergency management practice, traditional Chinese medicine management and overseas communication, health care, welfare and sustainable development and other topics.
In this meeting, Yinfeng Cryogenic introduced the vision of Yinfeng Biological Group and the whole life cycle health management service, which echoed the theme of "great health" of this conference. Relying on the whole chain of bioengineering industry such as cell and tissue organ storage, gene sequencing technology, cell application technology, cryogenic medical technology, health management and other bioengineering industries independently built by Yinfeng Biology, the whole life cycle health management continuously extends and integrates the resources of big health products and services according to the specific health risk factors at each stage of the cycle of human life from the beginning of germ cell integration to the final termination of life, and provides customers with one-stop, personalized and multi-scenario prevention and intervention services through online and offline forms.
In recent years, cryomedicine has attracted much attention due to its fruitful clinical application results and strong development momentum. Under the concept of the whole life cycle, the "life extension plan" was introduced, and the cryopreservation and resuscitation technology of various human tissues and organs including ovarian tissue, skin, severed fingers (toes), valves, blood vessels and other human tissues and organs has been mastered in detail.
Latest developments
Over the two days, the symposium was not only a collision of ideas but also seeds sown to advance social progress in life culture. The Shandong Yinfeng Life Science Public Welfare Foundation will continue to use technology as wings and culture as roots, collaborating with all sectors of society to enhance the quality of life for the Chinese people and build a human-centered life care system.
According to recent announcements by the Jinan Municipal Bureau of Science and Technology, 11 outstanding achievements from Jinan have been included in the 2025 "Shandong Outstanding Achievements Report" project. Among them is the globally first-of-its-kind ovarian tissue dual-activation technology developed by Shandong Silver Med Life Science Research Institute (Jinan).
Recently, Frigid Zone Medicine, an authoritative international journal in the field of cryomedicine, published an important review titled "Advances in the Detection Methods for Assessing the Viability of Cryopreserved Samples". Written by the team of Yinfeng Cryomedical Research Center, the article systematically reviews and analyzes various detection techniques currently used to evaluate the viability of cryopreserved cells, tissues, and organs. It also proposes key directions from the perspectives of methodological integration and future instrument development, offering crucial theoretical support and practical guidance for the long - term cryopreservation of complex tissues and organs.
Recently, the "Novel Technology for Ultra-Low Temperature Cryopreservation, Activation, and Transplantation of Human Ovarian Tissue," developed through a collaborative effort between Shandong Yinfeng Life Science Research Institute and Beijing University of Chinese Medicine Shenzhen Hospital, has been awarded the 2025 Shandong Refrigeration and Air Conditioning Science and Technology Award. This groundbreaking technology pioneers a new pathway for female fertility preservation, marking a significant leap in China’s interdisciplinary advancements in reproductive medicine and cryobiology.
On May 19, a delegation from the Chinese Training Workshop for Government Officials of Developing Countries visited the exhibition hall of Yinfeng Biological Group's Cryomedicine Research Center. Government officials from multiple countries gained in-depth insights into Yinfeng’s innovative achievements in cryobiomedicine, cell storage, genetic technology, and other fields. They engaged in discussions with the delegation on technology transfer and international cooperation, contributing to the building of a global community with a shared future for humanity.
Yinfeng Life Continuation Plan
Address: Yinfeng Biotechnology Park, 1758 Gangyuan 6th Road, High-tech Zone, Jinan City, Shandong Province
Zip Code: 250102
Telephone: 0086-0531-88897351
Mobile: 0086-19953155507
Mobile website
Official WeChat Public Number
Links:Red Cross Society of China丨Shandong Red Cross Society丨Shandong Provincial Health Commission | Yinfeng Group| Yinfeng Biological Group
All rights reserved©Yinfeng Life Continuation Powered by www.300.cn SEO
